Cargando…

Leveraging model-informed approaches for drug discovery and development in the cardiovascular space

Cardiovascular disease remains a significant global health burden, and development of cardiovascular drugs in the current regulatory environment often demands large and expensive cardiovascular outcome trials. Thus, the use of quantitative pharmacometric approaches which can help enable early Go/No...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dockendorf, Marissa F., Vargo, Ryan C., Gheyas, Ferdous, Chain, Anne S. Y., Chatterjee, Manash S., Wenning, Larissa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953982/ https://www.ncbi.nlm.nih.gov/pubmed/29353335 http://dx.doi.org/10.1007/s10928-018-9571-3

Ejemplares similares

Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study
por: Dockendorf, Marissa F., et al.
Publicado: (2018)

Leveraging big data to transform target selection and drug discovery
por: Chen, B, et al.
Publicado: (2016)

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology
por: Borsari, Chiara, et al.
Publicado: (2020)

Leveraging off higher plant phylogenetic insights for antiplasmodial drug discovery
por: Moyo, Phanankosi, et al.
Publicado: (2023)

PDUFA VI: It Is Time to Unleash the Full Potential of Model‐Informed Drug Development
por: Jain, Lokesh, et al.
Publicado: (2018)

Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis
por: Irham, Lalu Muhammad, et al.
Publicado: (2023)

Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
por: Domingo-Fernández, Daniel, et al.
Publicado: (2022)

Leveraging Devices, Data and Discovery for Smarter Healthcare in Japan
por: Sawa, Tomohiro
Publicado: (2011)

Leveraging Microbial Genomes and Genomic Context for Chemical Discovery
por: Kountz, Duncan J., et al.
Publicado: (2021)

Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma
por: Sen, Arko, et al.
Publicado: (2022)

Reflexive Spaces: Leveraging Resilience Into Healthcare Regulation and Management
por: Wiig, Siri, et al.
Publicado: (2021)

Digitally Enabled, Patient‐Centric Clinical Trials: Shifting the Drug Development Paradigm
por: Dockendorf, Marissa F., et al.
Publicado: (2020)

Systemic evolutionary chemical space exploration for drug discovery
por: Lu, Chong, et al.
Publicado: (2022)

Editorial: Leveraging machine learning for omics-driven biomarker discovery
por: Li, Sheng, et al.
Publicado: (2023)

Informal nutrition symposium: leveraging the microbiome (and the metabolome) for poultry production
por: Lee, Margie D., et al.
Publicado: (2021)

Social information seeking: leveraging the wisdom of the crowd
por: Shah, Chirag
Publicado: (2017)

Leveraging domain information to restructure biological prediction
por: Nan, Xiaofei, et al.
Publicado: (2011)

Optimization of lead compounds into on-demand, nonhormonal contraceptives: leveraging a public–private drug discovery institute collaboration(†)
por: Balbach, Melanie, et al.
Publicado: (2020)

Leveraging family-specific signatures for AMP discovery and high-throughput annotation
por: Waghu, Faiza Hanif, et al.
Publicado: (2016)

Leveraging cross-link modification events in CLIP-seq for motif discovery
por: Bahrami-Samani, Emad, et al.
Publicado: (2015)

Leveraging Uncertainty from Deep Learning for Trustworthy Material Discovery Workflows
por: Zhang, Jize, et al.
Publicado: (2021)

Bioinformatic workflow fragment discovery leveraging the social-aware knowledge graph
por: Diao, Jin, et al.
Publicado: (2022)

Expanding the drug discovery space with predicted metabolite–target interactions
por: Nuzzo, Andrea, et al.
Publicado: (2021)

Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors
por: Nigam, AkshatKumar, et al.
Publicado: (2023)

The Grand Challenges in Cardiovascular Drug Discovery and Development
por: Ohlstein, Eliot H.
Publicado: (2010)

Metadynamics simulations leveraged by statistical analyses and artificial intelligence-based tools to inform the discovery of G protein-coupled receptor ligands
por: Salas-Estrada, Leslie, et al.
Publicado: (2022)

Progress in Amyotrophic Lateral Sclerosis Gene Discovery: Reflecting on Classic Approaches and Leveraging Emerging Technologies
por: Smukowski, Samuel N., et al.
Publicado: (2022)

Leveraging PEPFAR for HIV drug equity
por: Hammond, Alessandro, et al.
Publicado: (2023)

The miscarriage circle of care: towards leveraging online spaces for social support
por: Alqassim, Mona Y., et al.
Publicado: (2022)

Leveraging Digital Health to Improve the Cardiovascular Health of Women
por: Azizi, Zahra, et al.
Publicado: (2023)

Leveraging data and information systems on the sustainable development goals
por: Novillo-Ortiz, David, et al.
Publicado: (2021)

Using Galaxy-P to leverage RNA-Seq for the discovery of novel protein variations
por: Sheynkman, Gloria M, et al.
Publicado: (2014)

Leveraging genome characteristics to improve gene discovery for putamen subcortical brain structure
por: Chen, Chi-Hua, et al.
Publicado: (2017)

Leveraging vibration of effects analysis for robust discovery in observational biomedical data science
por: Tierney, Braden T., et al.
Publicado: (2021)

Prediction of the P. falciparum Target Space Relevant to Malaria Drug Discovery
por: Spitzmüller, Andreas, et al.
Publicado: (2013)

Explicit interaction information from WikiPathways in RDF facilitates drug discovery in the Open PHACTS Discovery Platform
por: Miller, Ryan A., et al.
Publicado: (2018)

Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022
por: Xu, Keman, et al.
Publicado: (2023)

Leveraging shared connectivity to aggregate heterogeneous datasets into a common response space
por: Nastase, Samuel A., et al.
Publicado: (2020)

Leveraging genetic interactions for adverse drug-drug interaction prediction
por: Qian, Sheng, et al.
Publicado: (2019)

LEVERAGING DRUG-DRUG INTERACTIONS FOR PHARMACOLOGICAL EXTENSION OF HEALTHY LIFESPAN
por: Gruber, Jan
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i6e8b4k6pbhhr36enli89vj1ou